ArticleDiscoveries (Craiova, Romania)

Validation of commercially available ELISAs for the detection of circulating sclerostin in hemodialysis patients.

Sebastian F Mause et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.